Adenovirus-mediated antisense telomerase with cisplatin increased the susceptibility of cisplatin resistant ovarian cancer cell line

Journal of Microbiology and Biotechnology

Volumn 12, Issue 5, 2002, Pages 711-715

  Kim, Dae Shick ^a   Song, Joon Seok ^b   Lee, Kyu Wan ^b   Kim, Mee Hye ^c   Kim, Kyung Tai ^d   Kim, Hysook ^a   Kim, Young Tae ^b  

^a Sungkyunkwan University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Sewha Pediatric Clinic   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Adenovirus; Cisplatin; Ovarian cancer; Targeted cancer gene therapy; Telomerase

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; CISPLATIN; TELOMERASE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DEATH; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; OVARY CANCER; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE;

EID: 0036826649     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Adams, M., R. P. A'Hern, A. H. Calvert, J. Carmichael, P. M. Wilkinson, et al. 1998. Chemotherapy for ovarian cancer - a consensus statement on standard practice. Br. J. Cancer 78: 1404-1406.
2. Auersperg, N., S. Maines-Bandiera, J. H. Booth, H. T. Lynch, A. K. Godwin, and T. C. Hamilton. 1995. Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family history of ovarian cancer. Am. J. Obstet. Gynecol. 173: 558-565.
3. Bisoffi, M., A. E. Chakerian, M. L. Fore, J. E. Bryant, J. P. Hernandez, R. K. Moyzis, and J. K. Griffith. 1998. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA. Eur. J. Cancer 14: 1242-1249.
4. Blasco, M. A., H. W. Lee, M. P. Hande, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
5. Burger, A. A., J. A. Double, and D. R. Newll. 1997. Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur. J. Cancer 33: 638-644.
6. Chadeneau, C., K. Hay, H. W, Hirte, S. Gallinger, and S. Bacchetti. 1995. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55: 2533-2536.
7. Chu, G. 1994. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269: 787-790.
8. Counter, C. M., H. W. Irte, S. Bacchtti, and C. B. Harley. 1994. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA 91: 2900-2904.
9. Counter, C. M., J. Guota, C. B. Harley, B. Leber, and S. Bacchetti. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320.
10. Hiyama, E., L. Gollahon, T. Kataoka, K. Kuroi, T. Yokoyama, A. F. Gazdar, K. Hiyama, M. A. Piatyszek, and J. W, Shay. 1996. Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88: 116-122.
11. Hiyama, K., E. Hiyama, S. Ishioka, M. Yamakido, K. Inai, F. G. Gazddar, M. A. Piatyszek, and J. W. Shay. 1995. Telomerase activity in small-cell and non-small-cell lung cancer. J. Natl. Cancer Inst. 87: 895-901.
12. Jung, K.-E., M. Yang, K. Lee, H. Lim, J. Jung, B. Koo, L. S. Jeong, D.-H. Shin, C.-H. Lee, Y.-H. Cho, and Y. Lim. 2000. Structural study of antisense dimers, modified adenosine-thymidine phosporothioate. J. Microbiol. Biotechnol. 10: 889-896.
13. Kanazawa, Y., K. Ohkawa, and K. Ueda. 1996. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 225: 570-576.
14. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinric, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
15. Komata, T., Y. Kondo, S. Koga, S. C. Ko, L. W. Chung, and S. Kondo. 2000. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Ther. 7: 2071-2079.
16. Kondo, S., Y. Kondo, G. Li, R. H. Silverman, and J. K. Cowell. 1998. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16: 3323-3330.
17. Kondo, S. et al. 1998. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. FABES J. 12: 801-811.
18. Kondo, Y., S. Kondo, Y. Tanaka, T. Haqqi, B. P. Barna, and J. K. Cowell. 1998. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16: 2243-2248.
19. Norton, J. C., M. A. Piaryszek, W. E. Wright, J. W. Shay, and D. R. Corey. 1996. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnol. 14: 615-619.
20. Sahara, H., T. Nakanishi, M. Kitamoto, R. Nakashio, J. W. Shay, E. Tahara, G. Kajiyama, and T. Ide. 1995. Telomerase activity in human liver tissue: Comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res. 55: 2734-2736.
21. Sanes, J. R., J. L. R. Rubenstein, and J. F. Nicholas. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5: 3133-3142.
22. Schwartz, H. S., S. F. Juliao, M. F. Sciadini, L. K. Miller, and M. G. Butler. 1995. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 75: 1094-1099.
23. Sommerfeld, H. J., A. K. Meeker, M. A. Piatyszek, G. S. Bova, and D. S. Coffey. 1996. Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res. 56: 218-222.
24. Song, J. S., S. B. Kim, Y. H. Lee, K. W. Lee, H. H. Jung, M. H. Kim, K. T. Kim, R. Brown, and Y. T. Kim. 2002. Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells. J. Microbiol. Biotechnol. 12: 89-95.
25. Strahl, C. and E. H. Blackburn. 1996. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell Biol. 16: 53-65.
26. Tonew, M., E. Tonew, W. Gutsche, K. Wohlrabe, A. Stelzner, H. P. Schroer, and B. Heyn. 1984. Biological activity of transition metal complexes. Effect of dimethyl sulfoxide on the cytotoxic, antiviral and antitumoral properties of cisdichlorodiammineplatinum (II): "cisplatin." Zentralbl Bakteriol Mikrobiol Hyg [A] 257: 108-120.
27. Zamecnik, P. and M. L. Stephenson. 1978. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75: 280-284.